Vera Mucaj

802 total citations
8 papers, 621 citations indexed

About

Vera Mucaj is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Vera Mucaj has authored 8 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 3 papers in Molecular Biology and 1 paper in Genetics. Recurrent topics in Vera Mucaj's work include Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (2 papers). Vera Mucaj is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (2 papers). Vera Mucaj collaborates with scholars based in United States, Slovakia and France. Vera Mucaj's co-authors include M. Celeste Simon, Jessica E.S. Shay, Nicolas Skuli, T.S. Karin Eisinger‐Mathason, Michael S. Nakazawa, Sam S. Yoon, Lars Stangenberg, Qiong Qiu, Navid Sadri and David G. Kirsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Vera Mucaj

7 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Mucaj United States 7 384 371 130 97 81 8 621
Swathi V. Iyer United States 10 431 1.1× 246 0.7× 204 1.6× 54 0.6× 68 0.8× 11 606
Siv Beckman Sweden 11 473 1.2× 486 1.3× 199 1.5× 61 0.6× 78 1.0× 11 833
Danny A. Zwijnenburg Netherlands 17 641 1.7× 303 0.8× 234 1.8× 67 0.7× 74 0.9× 23 965
Christine Grignet‐Debrus Belgium 7 392 1.0× 308 0.8× 138 1.1× 41 0.4× 55 0.7× 9 647
Tomoshige Akino Japan 12 539 1.4× 317 0.9× 249 1.9× 77 0.8× 92 1.1× 14 795
Nadine Abu-Kaoud Qatar 8 405 1.1× 214 0.6× 209 1.6× 73 0.8× 45 0.6× 9 663
Abhijeet Deshmukh Australia 11 441 1.1× 281 0.8× 328 2.5× 56 0.6× 96 1.2× 11 713
Séverine Cruet-Hennequart Ireland 14 467 1.2× 158 0.4× 206 1.6× 123 1.3× 61 0.8× 15 735
Gvantsa Kharaishvili Czechia 18 404 1.1× 221 0.6× 347 2.7× 107 1.1× 153 1.9× 26 776
Swethajit Biswas United Kingdom 12 424 1.1× 249 0.7× 209 1.6× 35 0.4× 200 2.5× 22 690

Countries citing papers authored by Vera Mucaj

Since Specialization
Citations

This map shows the geographic impact of Vera Mucaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Mucaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Mucaj more than expected).

Fields of papers citing papers by Vera Mucaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Mucaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Mucaj. The network helps show where Vera Mucaj may publish in the future.

Co-authorship network of co-authors of Vera Mucaj

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Mucaj. A scholar is included among the top collaborators of Vera Mucaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Mucaj. Vera Mucaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Horne, Christine, et al.. (2022). Abstract 6346A: Privacy preserving record linkage of mortality data for oncology survival analyses. Cancer Research. 82(12_Supplement). 6346A–6346A.
2.
Mathew, Lijoy K., Peiwei Huangyang, Vera Mucaj, et al.. (2015). Feedback circuitry between miR-218 repression and RTK activation in glioblastoma. Science Signaling. 8(375). ra42–ra42. 20 indexed citations
3.
Eisinger‐Mathason, T.S. Karin, Vera Mucaj, Michael S. Nakazawa, et al.. (2015). Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis. Proceedings of the National Academy of Sciences. 112(26). E3402–11. 81 indexed citations
4.
Shay, Jessica E.S., Hongxia Z. Imtiyaz, Sharanya Sivanand, et al.. (2014). Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer. Carcinogenesis. 35(5). 1067–1077. 57 indexed citations
5.
Mucaj, Vera, N. Skuli, Bo Qiu, et al.. (2014). MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma. Oncogene. 34(17). 2204–2214. 53 indexed citations
6.
Eisinger‐Mathason, T.S. Karin, Minsi Zhang, Qiong Qiu, et al.. (2013). Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis. Cancer Discovery. 3(10). 1190–1205. 213 indexed citations
7.
Mathew, Lijoy K., Nicolas Skuli, Vera Mucaj, et al.. (2013). miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proceedings of the National Academy of Sciences. 111(1). 291–296. 88 indexed citations
8.
Mucaj, Vera, Jessica E.S. Shay, & M. Celeste Simon. (2012). Effects of hypoxia and HIFs on cancer metabolism. International Journal of Hematology. 95(5). 464–470. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026